rituximab,ibrutinib,Bendamustine
biogen,roche,novartis,janssen,abbvie
['lba7502', 'improve', 'shine', 'lymphoma', 'mantle,(-dismantle)']
adding ibrutinib to br and r maintenance in elderly pts with mantle cell lymphoma improved pfs by 50% (to 80.6 months) in phase 3 shine trial; however, no increase in os [#asco22 abstract lba7502] our story to follow soon. 
Medscape Oncology provides breaking medical news, references for drugs, diseases, and procedures, and free CME.